Receptors for the excitatory neurotransmitter glutamate have been classified into two broad families. Ionotropic glutamate receptors are coupled directly to cation channels and mediate fast excitatory synaptic responses at various synapses throughout the CNS (for reviews, see Collingridge and Lester, 1989; Monaghan et al., 1989) . The more recently discovered metabotropic glutamate receptors (mGluRs) are linked to second messenger systems via GTP-binding proteins (G-proteins) and participate in generation of slow synaptic responses and modulation of neuronal excitability (for reviews, see Schoepp et al., 1990; Conn and Desai, 1991) . To date, the most well characterized mGluR subtype is coupled to activation of phosphoinositide hydrolysis. However, relatively little is known about the other mechanisms of signal transduction employed by the mGluRs. A major advance in our understanding of mGluRs came with the recent cloning of four mGluR subtypes from rat brain (designated mGluR 1-mGluR4) (Houamed et al., I99 I; Masu et al., 199 I; Tanabe et al., 1992) . Studies of cloned mGluRs in expression systems such as Xenopus oocytes (Houamed et al., 199 1; Masu et al., 199 1; Tanabe et al., 1992) and Chinese hamster ovary cells (Aramori and Nakanishi, 1992) have yielded some information regarding the second messenger systems activated by mGluRs. However, biochemical responses to receptors expressed in such systems may not always reflect the second messenger systems employed by receptors in cells in which they are normally expressed. Thus, to gain a clear understanding of the signal transduction mechanisms employed by mGluRs, it will be important to characterize the responses to activation of native receptors and compare the pharmacological properties of those responses to those of the cloned receptors.
The recent discovery of selective mGluR agonists such as tram-1 -aminocyclopentane-1,3-dicarboxylic acid (trans-ACPD) (Palmer et al., 1989; Desai and Conn, 1990) has greatly facilitated the study of the effects of mGluR activation in brain slices and primary cell cultures. We recently reported that the active isomer of tvans-ACPD, 1 -aminocyclopentane-1 S,3R-dicarboxylic acid (lS,3R-ACPD), increases CAMP accumulation in rat hippocampal slices (Winder and Conn, 1992) . This increased CAMP accumulation appears to be mediated by an mGluR since it is not blocked by ionotropic receptor antagonists such as D-2-amino-5phosphonovaleric acid and 6-cyano-2,3-dihydroxy-7-nitroquinoxaline (CNQX), but is blocked by a putative mGluR antagonist L-2-amino-3-phosphonoproprionicacid (L-AP3) (Winder and Conn, 1992) . However, the mechanisms involved in lS,3R-ACPD-stimulated increases in CAMP accumulation are not known.
Previous studies indicate that excitatory amino acids (EAAs) other than lS,3R-ACPD increase CAMP accumulation in rat brain slices by a mechanism that is dependent on the presence of endogenous adenosine (Shimizu et al., 1974; Schmidt et al., 1977; Bruns et al., 1980) . Since mGluRs had not been discovered when these studies were performed, it was concluded that EAA-stimulated increases in CAMP accumulation were mediated by activation of ionotropic glutamate receptors, subsequent depolarization, and release of endogenous adenosine. However, it is now clear that agonists of a number of G-protein-linked receptors increase CAMP levels by potentiating CAMP responses to other receptors rather than by direct coupling to adenylate cyclase (Magistretti and Schorderet, 1985; Pile and Enna, 1986; Johnson and Minneman, 1987; Garbarg and Schwartz, 1988; Schaad et al., 1989) . It is possible that adenosine-dependent increases in CAMP accumulation are mediated by activation of receptors belonging to this class and that activation of these receptors increases CAMP levels by potentiating responses to extracellular adenosine. Indeed, basal levels of extracellular adenosine in brain have been estimated to be in a range near that required for activation of the adenylate cyclase-coupled A, adenosine receptors (Fredholm et al., 1984) . Thus, we performed a series of studies in which we tested the hypothesis that the mGluR-mediated increase in CAMP accumulation is dependent on the presence of endogenous adenosine and involves activation of an mGluR subtype that potentiates CAMP responses to other agonists.
Materials and Methods
Increases in CAMP accumulation were measured using a modification of the method of Shimizu et al. (1969) as described in Johnson and Minneman (1986) . This method involves measurement of agonist-induced accumulation of >H-cyclic AMP in rat hippocampal slices prelabeled with 'H-adenine. Briefly, cross-chopped hippocampal slices (350 x 350 pm) were prepared from male Sprague-Dawley rats (150-200 gm) and incubated in Kreb's bicarbonate buffer (KBB, 108 mM NaCl, 4.7 mM KCl, 2.5 mM CaCl,, 1.2 mM MgSO,, 1.2 mM KH,PO,, 10 mM glucose, and 25 mM NaHCO,), at 37°C for 15 min. Tissue was washed and incubated for 40 min in 15 ml of KRB containing 30 &i 'Hadenine (American Radiolabelled Chemicals, St. Louis, MO) and 6 pM unlabeled adenine. After several rinses with warm KRB, 25 ~1 aliquots of gravity packed slices were transferred to incubation tubes and incubated for 15 min with appropriate drugs (final volume, 0.5 ml). The reaction was terminated with 50 pl 77% trichloroacetic acid, and 25 ~1 of 10 mM cyclic AMP was added as a carrier. The tissue was homogenized and centrifuged (15 mitt, 17,000 x g), and 25 pl ofthe supematant was removed for determination of total radioactivity incorporated into the tissue. 'H-cyclic AMP in the remaining supematant was isolated by sequential elution through Dowex and then alumina columns. The results were expressed as a percentage conversion of total radioactivity to 'H-cyclic AMP. All incubations were at 37°C under an atmosphere of Olr CO, in a shaking water bath.
Materials. lS,3R-ACPD, lS,3S-ACPD, D-AP5, L-AP3, and CNQX were nurchased from Tocris Neuramin (Essex. UK). 1 R,3S-ACPD was a generous gift from Dr. James A. Mann (Lilly Research Laboratories). Theophylline, caffeine sodium benzoate, prostaglandin E, (PGE,), isoproterenol, 3-isobutyl-1 -methylxanthine (IBMX), vasoactive intestinal neptide (VIP), and 2-chloroadenosine (2-CA) were purchased from Sigma. Ad&to&e deaminase (ADA) was purchased from Boehringer Mannheim. 8-Cyclopentyl-1,3-dipropylxanthine (DPCPX), xanthine amine congener (XAC), and Ro20 1724 were purchased from Research Biochemicals Inc.
Results
Consistent with our previous report (Winder and Conn, 1992) incubation of cross-chopped hippocampal slices with lS,3R-ACPD resulted in a concentration-dependent increase in CAMP accumulation.
The increase in CAMP accumulation upon ad- dition of 100 PM lS,3R-ACPD was potentiated in the presence of the cyclic nucleotide phosphodiesterase inhibitor Ro20 1724
is not a mechanism of 1 S,3R-ACPD-stimulated CAMP increases.
lS,3R-ACPLMtimulated increase in CAMP accumulation is inhibited by ADA and enhanced by blockade of adenosine uptake
The hypothesis that adenosine mediates 1 S,3R-ACPD-stimulated CAMP increases in hippocampal slices was tested by measuring the effect of lS,3R-ACPD (100 PM) on CAMP accumulation in the presence of ADA. ADA inhibited lS,3R-ACPD-stimulated CAMP increases in a concentration-dependent manner with an IC,, of approximately 0.5 U/ml (Fig. 2 ).
ADA at a concentration of 10 U/ml completely inhibited CAMP increases stimulated by 1 S,3R-ACPD. The concentration of ADA needed to inhibit lS,3R-ACPD-stimulated CAMP accumulation was similar to the concentration previously shown to inhibit the CAMP response to glutamate (Schmidt et al., 1977; Bruns et al., 1980) . Another prediction of the hypothesis that lS,3R-ACPDstimulated CAMP accumulation is mediated by endogenous adenosine is that blockade of adenosine uptake should enhance the CAMP response to lS,3R-ACPD.
We measured the effect of the adenosine uptake blocker dipyridamole on lS,3R-ACPD-stimulated increases in CAMP accumulation. Dipyridamole ( 10 PM) induced a slight (= 1.5 x basal) increase in CAMP accumulation when added alone and markedly potentiated the response to 1 S,3R-ACPD (100 PM) (Fig. 3) .
lS,3R-ACPD-stimulated increase in CAMP accumulation is dependent on activation of AZ6 adenosine receptors Adenosine stimulates CAMP accumulation in rat hippocampal slices by activating the A,, subtype of adenosine receptor (Bruns et al., 1986; Lupica et al., 1990; Olah and Stiles, 1992) . Thus, it is possible that activation of mGluRs increases CAMP accumulation by increasing A,,-mediated effects of adenosine. Therefore, we next tested the hypothesis that the lS,3R-ACPD-stimulated increase in CAMP accumulation was dependent upon activation of A,, adenosine receptors. This was accomplished by determining the effects of adenosine receptor antagonists with a range of affinities at A, adenosine receptors on CAMP responses to lS,3R-ACPD and adenosine. In these studies, we used concentrations of 1 S,3R-ACPD (100 PM) and adenosine (30 PM) that elicited CAMP responses of similar magnitudes. The responses to these concentrations of lS,3R-ACPD and adenosine were 207 + 18% and 232 rf: 30% of basal respectively. The adenosine receptor antagonists used in these experiments included a number of xanthine derivatives (IBMX, DPCPX, XAC, caffeine, and theophylline) and one non-xan- thine (CGS 15943). IBMX inhibits cyclic nucleotide phosphodiesterases at the concentrations needed to block adenosine receptors (Choi et al., 1988) . Thus, experiments with this antagonist were performed in the presence of the phosphodiesterase inhibitor Ro20 1724 (200 PM). All antagonists tested inhibited both lS,3R-ACPD-stimulated and adenosine-stimulated CAMP accumulation in a concentration-dependent manner (Fig. 4) . The rank order and absolute values of the IC,, values of these compounds at inhibiting responses to the two agonists were similar. These values were also similar to the previously reported K, values of these antagonists at A, adenosine receptors (for review, see Jacobsen et al., 1992) . Regression analysis of the IC,, values of these antagonists at inhibiting responses to lS,3R-ACPD versus inhibiting responses to adenosine yielded a significant correlation, with a correlation coefficient of 0.968 0, < 0.02) (Fig. 5) . These data are consistent with the hypothesis that mGluR-mediated increases in CAMP accumulation are dependent upon activation of A,, adenosine receptors.
S,3R-ACPD potentiates CAMP responses to endogenous adenosine
The data presented to this point suggest that activation of A, receptors by adenosine is necessary for lS,3R-ACPD stimulation of CAMP accumulation in the hippocampus. One possible mechanism by which lS,3R-ACPD could exert this effect is by increasing release of adenosine from cellular stores. However, previous studies suggest that other EAAs potentiate CAMP responses to adenosine and other agonists (Schmidt et al., 1977; Bruns et al., 1980; Schaad et al., 1990 ). Thus, it is possible that an mGluR subtype exists that belongs to the class of receptors that potentiate CAMP responses to agonists of other G,-coupled receptors. If so, lS,3R-ACPD could increase CAMP accumulation by potentiating the CAMP response to low levels of adenosine that are already present in the extracellular space. If this is the mechanism of lS,3R-ACPD stimulation of CAMP accumulation, it is predicted that lS,3R-ACPD will potentiate CAMP responses to application of exogenous adenosine and other agonists of receptors that are coupled to adenylate cyclase. Thus, we measured the effect of increasing concentrations of the adenosine receptor agonist 2-CA on CAMP accumulation in the presence and absence of lS,3R-ACPD. lS,3R-ACPD (100 PM) induced a clear potentiation of the CAMP response to all concentrations of 2-CA (Fig. 6) . We also examined the effects of lS,3R-ACPD on the CAMP responses to agonists of other receptors that are coupled to activation of adenylate cyclase. 1 S,3R-ACPD markedly potentiated the CAMP responses to all agonists tested (Fig. 7) . In addition to 2-CA, these included PGE, (100 PM), VIP (100 nM), and isoproterenol(l0 PM).
We next compared the pharmacological profile of lS,3R-ACPD-induced increases in basal CAMP accumulation with that of lS,3R-ACPD-induced potentiation of 2-CA-stimulated CAMP accumulation to determine if these responses are mediated by the same receptor. As shown in Figure 8 , A and B, both lS,3R-and lS,3S-ACPD stimulate an increase in CAMP over basal and potentiate the response to 50 PM 2-CA, while 1 R,3S-ACPD has no effect on basal or 2-CA-stimulated CAMP accumulation. Also, neither 500 PM D-AP~ nor 200 pM CNQX blocked the lS,3R-ACPDstimulated increases in CAMP accumulation or potentiation of the response to 50 PM 2-CA, while 500 PM L-AP3 significantly attenuated both responses (data not shown). These data suggest that both potentiation of responses to 2-CA and increases in basal CAMP are mediated by activation of an mGluR. It is interesting to note that ADA does not appear to reduce CAMP accumulation to a level below that seen in the absence of added agonists (Fig. 2) . This suggests that extracellular adenosine is not present in sufficient concentrations to influence basal CAMP turnover appreciably. This brings into question the hypothesis that the resting extracellular adenosine concentration is high enough to allow a CAMP response to lS,3R-ACPD without a lS,3R-ACPD-induced increase in adenosine release. To address this issue, we performed an experiment wherein the endogenous adenosine was removed by addition of ADA and then replaced in the form of the ADA-resistant 2-CA at a concentration that does not stimulate increases in basal CAMP accumulation. As shown in Figure 9 , application of ADA (5 U/ml) abolished the increase in CAMP induced by lS,3R-ACPD. thermore, 750 nM 2-CA had no effect on CAMP accumulation when added alone. However, when 100 PM lS,3R-ACPD was added in the presence of 750 nM 2-CA, it elicited a response that was similar to that elicited by 100 PM lS,3R-ACPD in slices that were not incubated with ADA and 2-CA. (Fig. 9) . These data indicate that activation of mGluRs is capable of stimulating an increase in CAMP accumulation to a concentration of adenosine that alone is not capable of stimulating detectable increases in CAMP.
Discussion
We present evidence for the existence of an mGluR subtype that belongs with the growing number of receptors that interact synergistically with G,-coupled receptors to increase CAMP accumulation. Activation of members of this class of receptors in the absence of other agonists generally has no effect on CAMP accumulation. However, agonists of these receptors markedly potentiate CAMP responses to activation of other receptors that are directly coupled to adenylate cyclase via G,. Receptors that belong to this class include (Y, adrenergic receptors, H, histaminergic receptors, and others (Magistretti and Schorderet, 1985; Pile and Enna, 1986; Johnson and Minneman, 1987; Garbarg and Schwartz, 1988; Schaad et al., 1989 ). In addition, previous studies have shown that other EAAs increase CAMP responses to other agonists (Schmidt et al., 1977; Bruns et al., 1980; Schaad et al., 1990 ). However, it was not clear from these earlier studies . Replacement of endogenous adenosine with a low concentration of 2-CA. Each bar represents the mean (LSEM) of three experiments, each done in triplicate. ACPD, lS,3R-ACPD (100 PM); ADA, adenosine deaminase (5 U/ml); 2-CA, 2chloroadenosine (750 nm). *, p < 0.001 versus basal. There was no significant difference between ACPD and ACPD + ADA + 2-CA.
whether this effect was mediated by mGluRs or ionotropic glutamate receptors. We now report that the selective mGluR agonist lS,3R-ACPD potentiates CAMP responses to adenosine, PGE,, VIP, and isoproterenol, all of which activate receptors that are positively coupled to adenylate cyclase. This response is not blocked by selective antagonists of ionotropic glutamate receptors but is blocked by the putative mGluR antagonist L-AP3. Thus, it is likely that EAA-induced potentiation of CAMP response is mediated by an mGluR.
At present, the mechanism by which activation of this class of receptor potentiates G,-mediated increases in CAMP accumulation is not known. However, one possible mechanism was recently proposed by Tang and Gilman (199 l) , who showed in cultured insect ovarian Sfp cells that although the By subunits of a heterotrimeric (cr&) G-protein inhibit type I adenylate cyclase, these same subunits potentiate activation of type II adenylate cyclase by the cy subunit of G,. Furthermore, Federman et al. (1992) showed that activation of cyz adrenergic receptors increases CAMP levels in cells transfected with the type II adenylate cyclase in a pertussis toxin-sensitive manner. Further studies in their system suggested that this is mediated by generation of free /3r subunits, which potentiate q-mediated activation of type II adenylate cyclase. Type II adenylate cyclase is abundant in rat brain (Feinstein et al., 1991) . We have supplied evidence that lS,3R-ACPD-stimulated CAMP accumulation is not mediated by activation of phosphoinositide hydrolysis or protein kinases (Winder and Conn, 1992) . Thus, it will be interesting to determine whether the lS,3R-ACPD-induced enhancement of CAMP responses to other neurotransmitters is mediated by a similar generation of /3-r subunits and activation of type II adenylate cyclase.
We also present evidence that lS,3R-ACPD-stimulated increase in basal CAMP accumulation in hippocampal slices is mediated by potentiation of the CAMP response to endogenous adenosine. We found that 1 S,3R-ACPD-stimulated increase in CAMP levels is blocked by addition of ADA or adenosine receptor antagonists, and is potentiated by the adenosine uptake blocker dipyridamole. Furthermore, analysis of the IC,, values of various adenosine receptor antagonists at inhibiting lS,3R-ACPD-stimulated CAMP accumulation suggests that this effect is mediated by activation of A, adenosine receptors. Taken together with previous findings (Bruns et al., 1986; Jarvis and Williams, 1988; Lupica et al., 1990) these data suggest that the CAMP response to lS,3R-ACPD is dependent on activation of the A,, adenosine receptor subtype.
Thus, potentiation of responses to low levels of endogenous Previous studies suggest that adenosine also plays a role in mediating the effects of glutamate and other EAAs on CAMP adenosine could entirelv account for 1 S.3R-ACPD-stimulated accumulation in brain slices. It was concluded in these earlier studies that the EAAs tested stimulated CAMP formation indirectly through release of adenosine (Schmidt et al., 1977; Bruns et al., 1980) . We performed studies to determine whether the 1 S,3R-ACPD-stimulated increase in basal CAMP accumulation is mediated by an increase in adenosine release or potentiation of responses to adenosine that is already present in the extracellular space. If potentiation of the CAMP response to adenosine is sufficient to account for lS,3R-ACPD-stimulated increases in basal CAMP accumulation, we would predict lS,3R-ACPD could potentiate the response to low concentrations of adenosine that do not elicit a detectable CAMP response in the absence of mGluR agonists (Delapp and Eckols, 1992) . This potentiation should result in a detectable CAMP response of a magnitude similar to that normally elicited by lS,3R-ACPD. Thus, we performed an experiment in which the CAMP response to 1 S,3R-ACPD was abolished by removal of endogenous adenosine with ADA. We then replaced the endogenous adenosine with 2-CA, an adenosine analog that is not a substrate for ADA. Extracellular adenosine concentrations in hippocampal slices have been estimated to be in the range of 500 nM to 1 FM (Fredholm et al., 1984) . Adenosine and 2-CA have virtually identical affinities A1 adenosine receptors (Bazil and Minneman, 1986; Bruns et al., 1986) . Therefore, we replaced endogenous adenosine with 750 nM 2-CA. This concentration of 2-CA had no detectable effect on CAMP accumulation when added alone. However. in ADA-treated slices. this low concentration of 2-CA completely restored the ability of lS,3R-ACPD to stimulate increases in CAMP accumulation. Under these conditions, 1 S,3R-ACPD could not exert its effect by stimulating adenosine release. lysis (for review, see Schoepp et al., 1990; Conn and Desai, 199 l) , inhibition of forskolin-stimulated CAMP accumulation (Cartmell et al., 1992; Schoepp et al., 1992) and inhibition of a calcium conductance (Lester and Jahr, 1990) . Furthermore, activation of mGluRs elicits a variety of electrophysiological effects in rat hippocampal slices. For example, Irons-ACPD depolarizes pyramidal cells with an accompanying increase in input resistance, blocks spike frequency adaptation (Charpak et al., 1990; Charpak and Gahwiler, 199 1; Desai and Corm, 199 l) , broadens the action potentials (Hu and Storm, 199 l) , and decreases both inhibitory (Desai and Corm, 199 1) and excitatory (Baskys and Malenka, 199 1) synaptic transmission. In addition, mGluRs in the hippocampus may play an important role in long-term potentiation (McGuinness et al., 1991; Otani and Ben-Ari, 199 1) and epileptogenesis (Iadorola et al., 1986; Sacaan and Schoepp, in press ). In future studies, it will be important to determine which mGluR subtypes and corresponding second messenger systems mediate these responses to mGluR activation. blocked by concentrations of TTX that completely block cell firing (Winder and Corm, 1992) suggesting that the response to IS,3R-ACPD is not likely to be mediated by depolarizationinduced adenosine release.
Although our data do not entirely rule out the possibility that lS,3R-ACPD induces a slight increase in adenosine release, it is possible that the pool of extracellular adenosine is sufficient to allow stimulation of increases in CAMP levels upon activation of mGluRs. However, it should be noted that studies by Hoehn and White (1990a,b) show that other EAAs evoke adenosine release in rat cortical slices. Thus, under normal conditions, glutamate's actions on ionotropic and metabotropic receptors could act synergistically to increase CAMP levels by increasing adenosine release and potentiating the CAMP response to adenosine receptor activation.
To date, stimulation of mGluRs has been shown to activate at least four signal transduction mechanisms in rat hippocampal slices. In addition to the increases in CAMP accumulation reported here, these include increased phosphoinositide hydro-
